FDA & CDC Halt Johnson & Johnson Vaccine To Review ‘Rare’ Blood Clot Cases

Fact checked
Johnson and Johnson

US health authorities have halted the Johnson & Johnson vaccine roll out after six women developed ‘rare’and ‘severe’ types of blood clots.

The Food and Drug Administration (FDA) said that six cases had been reported and it was acting “out of an abundance of caution”.

All six cases were in women aged between 18 and 48 and with symptoms appearing six to 13 days after vaccination.

In a joint statement the FDA and the Centers for Disease Control (CDC) and Prevention said they were “reviewing data involving six reported US cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine”.

BBC reports: Johnson & Johnson said it was also delaying its vaccine rollout in Europe.

The US move follows similar rare cases in the AstraZeneca vaccine, which has prompted some curbs in its use.

The US has by far the most confirmed cases of Covid-19 – more than 31 million – with more than 562,000 deaths, another world high.

The picture for the virus in the US is complicated, though, with some areas in the north seeing surges in infections, the south less, and with the figures not always reflecting inoculation numbers.

The Johnson & Johnson jab was approved in the US on 27 February and its use has been more limited so far than that of the Pfizer-BioNTech and Moderna doses.

Nevertheless, the government had hoped for hundreds of thousands of vaccinations of the jab every week as it is single-shot and its storage at common refrigerator temperatures makes it easier to distribute.

It is also known as the Janssen vaccine, named after the Belgian company that makes it.

South Africa became the first country in the world to administer the jab, and nearly 300,000 health workers have received it since mid-February. Health authorities there have not yet decided whether the roll out will continue.

The vaccine is yet to be approved in the UK, although 30 million doses are on pre-order. The Department of Health said the rollout delay would not affect vaccine supplies in the UK, or derail the aim to offer a jab to all adults by the end of July.


  1. I’m sure rge deceased are ever so grateful dor their caution as government safety officers controlling public health They clearly really can be trusted to make declarations concerning products preparedness for administration in compulsory programmes Trust them with your life .Theyre the experts I wonder if they will attend the funerals or be ” too busy working hard as well respected members of their community ” .

  2. From the same company that brought you the untested toxic metal on metal artificial hip. J and J!

  3. Overall 1 in 333 worldwide had bad reactions from M-Rna`s and J&J but a huge% had some kind of reaction.many things can cause reactions and long term affects being unknown leads one to find their own way to what works for them.1-3% death rate from covid 19 many long haulers disabled and somewhat failing vaccines.I would get antibodys tested at many levels for immunoglobulins and if you have the covid19 antobodys that seems to buy at least 90 days and some vaccines seem to buy a few months it`s all a gamble but I don`t want M-RNA`s at all unless I have too and than if I was rich i would get the vaccine in a hospt in a drip with full backup from a medical team

  4. Birth control pills having had covid before and health and diet many factors to weigh age so on less reactions with age it seems but also less defence.Those that totally need the vaccine it may not help them much and those that don`t seem to need it much it could be a bad gamble?.To me J&J seems the only standard type vaccine but than they say the next round may not work next year so it looks like we are CYAèd

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.